Golden Valley Memorial Healthcare in the News

Rated as One of the Top Hospitals in Missouri

Golden Valley Memorial Healthcare, a leading rural healthcare organization, has been rated among the top 10 hospitals in Missouri in a national hospital ranking index by the Lown Institute, a nonpartisan think tank based in Brookline, Mass.

The index, which was released in early July, assessed nearly 3,300 hospitals nationwide and rolls up scores from three categories, seven sub-components, and 42 detailed metrics to provide a unique and holistic ranking of hospital performance.

The hospitals on the Lown ranking received high value of care grades based on low use of unnecessary services. The quality of care metrics evaluated patient safety and health outcomes. Hospitals also earned marks in civic leadership by showing a commitment to diversity, inclusion, and community health.

These three pillars, along with data from the Internal Revenue Service, the Centers for Medicare and Medicaid, the Bureau of Labor Statistics, and the Securities and Exchange Commission, culminated in the ranking of hospitals. Overall, GVMH received an “A” for its ratings in these areas.

“We are extremely proud to have received an A ranking in the Lown Institute Hospitals Index and to be included as one of the top 10 hospitals in the entire state,” said Craig Thompson, CEO at GVMH. “Our communities rely on us in times of need and trust us with their lives, so it is important for us to deliver high-quality care. This index confirms the commitment and dedication of our staff.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy